Blood biomarkers and association with clinical outcomes in metastatic castration-resistant prostate cancer (mCRPC): Prespecified longitudinal analysis from the ACIS study of apalutamide (APA) or placebo combined with abiraterone acetate plus prednisone (AAP) Meeting Abstract
| Authors: | Efstathiou, E.; Attard, G.; Lucas, J.; Thomas, S.; Gormley, M.; Aguilar-Bonavides, C.; Flaig, T. W.; Franke, F.; Goodman, O. B.; Oudard, S.; Pieczonka, C. M.; Li, S.; Dibaj, S.; Brookman-May, S. D.; Yeruva, K.; McCarthy, S. A.; Steuber, T.; Suzuki, H.; Rathkopf, D. E.; Saad, F. |
| Abstract Title: | Blood biomarkers and association with clinical outcomes in metastatic castration-resistant prostate cancer (mCRPC): Prespecified longitudinal analysis from the ACIS study of apalutamide (APA) or placebo combined with abiraterone acetate plus prednisone (AAP) |
| Meeting Title: | 2022 ASCO Genitourinary Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 40 |
| Issue: | 6 Suppl. |
| Meeting Dates: | 2022 Feb 17-19 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2022-02-20 |
| Language: | English |
| ACCESSION: | WOS:000771008900144 |
| DOI: | 10.1200/JCO.2022.40.6_suppl.142 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 142 -- Meeting was conducted online as well as in person -- Source: Wos |
